居里 CRIS 深 沪
已收盘 10-02 16:00:00 美东时间
0.8034
-0.027
-3.29%
华盛通- 最 高0.8388
- 今 开0.8388
- 成交量 10.03万股
- 最 低 0.8034
- 昨 收 0.8307
- 总市值 194.83万
- 52周最高 33.60
- 市盈率 静 --
- 换手率 4.14%
- 52周最低 0.80
- 委 比 63.96%
- 总股本 242.51万
- 历史最高 11300.00
- 量 比 0.67
- 振 幅 4.26%
- 历史最低 0.8034
- 每 手 1
- 风险率 9.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多稀土废渣中提取出医用阿尔法核素
20日，记者从南华大学获悉，该校韦悦周教授团队从稀土废渣中直接分离并获得高纯度阿尔法（α）核素铅-212及其前体核素钍-228，成功实现单批次从公斤级稀土废渣中...
08-21 08:30
稀土矿渣可直接提取医用阿尔法核素
光明日报长沙8月20日电（记者禹爱华通讯员夏文辉）近期，南华大学核科学技术学院韦悦周教授团队从稀土矿渣中直接分离得到高纯度的阿尔法核素铅-212及其前体核素...
08-21 03:50
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
HC Wainwright & Co. Reiterates Buy on Curis, Maintains $43 Price Target
HC Wainwright & Co. analyst Sara Nik reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $43 price target.
08-17 18:14
Curis Inc.’s 1-for-20 Reverse Split Raises Liquidity Concerns and Odd-Lot Trading Risks
Curis Inc. (CRIS) has disclosed a new risk, in the Share Price & Shareholde...
08-16 14:01
Curis prices $5.6 million public offering
Curis (CRIS) announced the pricing of its public offering with certain new and existing healthcare-focused institutional investors for the purchase and sale of 3.73M shares of common stock of the comp...
08-13 20:40
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
LEXINGTON, Mass., Aug. 13, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule I...
08-13 20:00
Curis Regains Nasdaq Compliance, Faces One-Year Monitoring
Curis ( ($CRIS) ) has shared an update. On July 24, 2026, Curis, Inc. received ...
07-31 05:20
Curis Doses First Five Patients in TakeAim CLL Study
LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule I...
07-30 20:00
美股大行评级 | 最高120美元！大小摩等7家大行集体上调英特尔目标价；汇丰首予SpaceX"持有"评级，目标价115美元
今日重点评级关注：HC Wainwright & Co.：维持居里"买入"评级，目标价从17美元升至43美元；花旗：维持Klaviyo"买入"评级，目标价从31美元升至34美元
07-27 14:02
